Persistence among osteoporotic patients having started weekly oral bisphosphonate therapy

被引：0
|
作者：
Sheehy, Odile [1 ]
Kindundu, Christian [2 ]
Barbeau, Martin [2 ]
LeLorier, Jacques [1 ]
机构：
[1] CHUM, Pharmacoepidemiol & Pharmacoecon Unit, Res Ctr, Montreal, PQ, Canada
[2] Novartis Pharmaceut Canada, Dorval, PQ, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
027
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [1] Differences in persistence among different weekly oral bisphosphonate medications
    O. Sheehy
    C. M. Kindundu
    M. Barbeau
    J. LeLorier
    Osteoporosis International, 2009, 20
  • [2] Differences in persistence among different weekly oral bisphosphonate medications
    Sheehy, O.
    Kindundu, C. M.
    Barbeau, M.
    LeLorier, J.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (08) : 1369 - 1376
  • [3] Persistence and compliance with bisphosphonate therapy among postmenopausal osteoporotic women: A comparison between daily and weekly regimens.
    Huybrechts, KF
    Ishak, KJ
    Proskorovsky, I
    Caro, JJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S397 - S398
  • [4] Persistence and compliance with bisphosphonate therapy among post-menopausal osteoporotic women
    Cramer, J
    Amonkar, MM
    Hebborn, A
    Suppapanya, N
    VALUE IN HEALTH, 2004, 7 (06) : 724 - 724
  • [5] Treatment patterns among postmenopausal osteoporotic women starting on daily or weekly bisphosphonate therapy
    Huybrechts, KF
    Ishak, KJ
    Proskorovsky, I
    Caro, JJ
    Levinton, C
    VALUE IN HEALTH, 2005, 8 (06) : A11 - A12
  • [6] Does dosing regimen impact persistence with bisphosphonate therapy among postmenopausal osteoporotic women?
    Cramer, JA
    Amonkar, MM
    Hebborn, A
    Suppapanya, N
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S448 - S448
  • [7] Persistence of weekly oral bisphosphonate therapy: Wasted drug and fracture costs due to early discontinuation
    Sheehy, Odile
    Kindundu, Christian
    Barbeau, Martin
    LeLorier, Jacques
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S78 - S79
  • [8] Persistence and compliance with daily and weekly bisphosphonate therapy over 3 years.
    Curtis, Jeffrey R.
    Amonkar, Mayur M.
    Mucha, Lisa
    Barr, Charles E.
    Saag, Kenneth G.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S84 - S85
  • [9] Persistence with oral bisphosphonate therapy is high amongst patients followed in a DGH osteoporosis clinic
    Prowse, E
    McGetrick, D
    Thompson, V
    Hakim, AJ
    Doyle, DV
    RHEUMATOLOGY, 2005, 44 : I35 - I35
  • [10] Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures
    Sheehy, O.
    Kindundu, C.
    Barbeau, M.
    LeLorier, J.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (09) : 1583 - 1594
12345